Assessment and Management of Hepatobiliary Disease

Hepatic Transport Mechanisms, Intrahepatic Cholestasis and Gallstone Disease.- Liver Transplantation: State of the Art.- Mathematical Models for the Study of Liver Metabolism.- Mechanisms of Hepatic Fatty Acid Uptake.- Vesicular Transport of Fluid Phase Markers by Hepatocytes.- The Hepatic Uptake of Organic Anions: an Overview.- Mechanisms of Transport of Tauroconjugated Bile Acids in the Hepatocyte: Functional Significance.- Determinants of Biliary Cholesterol Secretion.- The Enterohepatic Circulation of Sulfated and Nonsulfated Bile Acids.- Esterogens and Bile Secretion.- Transport of UDPG in Vitro and Reversal of Ethanol-Induced Effects.- Associated Factors in Gallstone Disease.- Epidemiology of Gallstone Disease in Hungary.- The Role of the Gallbladder in Cholesterol Gallstone Pathogenesis.- Mechanism of Gallstone Formation in Obese Subjects.- Medical Treatment of Cholesterol Gallstones: Present and Future.- Bile Acid Treatment of Cholesterol Gallstones: A Reappraisal.- Biliary Lipid Composition after Endoscopic Sphincterotomy in Postcholecystectomy Patients: Effect of Short-Term Ursodeoxycholic Acid Administration.- Concluding Remarks.- Assessment of Liver Function.- Drug-Induced Liver Injury.- Biochemical Liver Tests: Recent Developments and Challenges.- Should Serum Bile Acid Determinations be performed Routinely in Patients with Liver Disease?.- Clinical Significance of Serum Bilirubins: Recent Advances.- Enzyme Pattern Changes in Preneoplastic and Neoplastic Lesions of the Liver.- The Value of Quantitation of Liver Function.- Quantitation of Liver Function: Antipyrine Metabolism, an Update.- Antipyrine Clearance: Evaluation of Simplified Methods in Chronic Liver Diseases.- Preoperative Care of Adult Patients Chosen for Liver Transplantation.- Assessment of Liver Function Before and After Liver Transplantation.- Hormones and Liver: Some Aspects of the Problem.- Effects of Thyroid Hormone Administration and of Thyroidectomy on the Metabolism of Bilirubin in Rats.- Comparison of Some Parameters of the Drug-Metabolizing Enzyme System and Liver Function Tests in Different Hepatic Diseases.- Interaction of Ethanol with Hepatic Drug Metabolism.- Antioxidant and Immunomodulant Effect of Hepatoprotective Drugs.- Stimulating Influence of a Flavonolignane Derivative on Proliferation, RNA Synthesis and Protein Synthesis in Liver Cells.- Renal Functional Impairment in Cirrhosis.- Pathophysiology of Cirrhotic Ascites.- Treatment of Ascites.- Low-Sodium Diet in the Management of Ascites in the Cirrhotic Patient.- Treatment of Refractory Ascites by Concentrated Ascitic Fluid Reinfusion.- Concluding Remarks.- Management of Liver Disease.- Liver and Aging.- Prognosis of Advanced Liver Disease.- Virus and Host Factors in the Evolution of Chronic Hepatitis Type B: Choice of Treatment.- Antiviral Treatment of Chronic Hepatitis.- Autoimmune Hepatitis: Diagnosis and Treatment.- Serum ?2-microglobulin and Anti- ?2m Antibodies in Chronic Liver Disease.- Treatment of Liver Cirrhosis.- Drug Therapy for Alcoholic Liver Disease.- Silymarin Treatment in Patients with Cirrhosis of the Liver—A Prospective Study.- Protein Malnutrition in Chronic Liver Disease: Corrective Measures.- The Management of Primary Biliary Cirrhosis.- Impaired Calcitonin Response to Intravenous Calcium Load in Primary Biliary Cirrhosis.- Prevention of Upper Gastrointestinal Bleeding in Cirrhotic Patients.- Prophylactic Treatment of First Variceal Bleeding in Cirrhotics with Nadolol or Ranitidine: A Prospective Randomized Study.- Hemodynamic and Clinical Evaluation of Nadolol in the Treatment of Portal Hypertension in Patients with Cirrhosis.- The GABA Hypothesis of the Pathogenesis of Hepatic Encephalopathy: Current Status.- Lactitol in the Prevention of Recurrent Hepatic Encephalopathy in Shunted Cirrhotic Patients. Preliminary Results of a Controlled Trial.- Concluding Remarks.